Renal outcomes of agalsidase beta treatment for Fabry disease: Role of proteinuria and timing of treatment initiation
David G. Warnock, Alberto Ortiz, Michael Mauer, Gabor E. Linthorst, João P. Oliveira, Andreas L. Serra, László Maródi, Renzo Mignani, Bojan Vujkovac, Dana Beitner-Johnson, Roberta Lemay, Alexander Cole, Einar Svarstad, Stephen Waldek, Dominique P. Germain, Christoph Wanner
Dive into the research topics of 'Renal outcomes of agalsidase beta treatment for Fabry disease: Role of proteinuria and timing of treatment initiation'. Together they form a unique fingerprint.